LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

Shackelford, David B., Abt, Evan, Gerken, Laurie, Vasquez, Debbie S., Seki, Atsuko, Leblanc, Mathias, Wei, Liu, Fishbein, Michael C., Czernin, Johannes, Mischel, Paul S., Shaw, Reuben J.·2013·Cancer Cell
DOI 10.1016/j.ccr.2012.12.008

Cited by (585)

Items 501–585 of 585

  1. A redox-dependent mechanism for AMPK dysregulation interrupts metabolic adaptation of cancer under glucose deprivation
    Younghwan Lee, Yoko Itahana, Choon Chen Ong, Koji Itahana · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
    Phaedra C. Ghazi, Kayla T. O’Toole, Sanjana Srinivas Boggaram, Michael T. Scherzer, Mark R. Silvis, Yun Zhang, Madhumita Jagannathan‐Bogdan, Bryan D. Smith, Guillermina Lozano, Daniel Lee Flynn et al. · 2024 · eLife
  3. Modeling compound lipid homeostasis using stable isotope tracing
    Karl A. Wessendorf-Rodriguez, Maureen L. Ruchhoeft, Ethan L. Ashley, Hector M. Galvez, Christopher W. Murray, Yi Huang, Grace H. McGregor, Shrikaar Kambhampati, Reuben J. Shaw, Christian M. Metallo · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  4. AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
    Zhen Sun, Bernard Linares, Cassidy Urdiales, Fiyad Al-sarmi, Nagireddy Putluri, Jeanine L. Van Nostrand · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis
    Lin Ma, Jing Zhang, Zi Dai, Pei Liao, Jieshan Guan, Zhijie Luo · 2025 · Frontiers in Immunology
  6. Alu-Sc-mediated exonization generated a mitochondrial LKB1 gene variant found only in higher order primates
    Ivan Tan, Sonia Pankaj Chothani, Hong Hwa Lim, Kong‐Peng Lam · 2025 · Scientific Reports
  7. Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics
    Chiyi Xiong, Boping Jing, Qizhen Cao, Junjie Li, Merve Alpay, Haiyan Chen, Wai-Kin Chan, Huamin Wang, Amir Mohammad Gholizadeh, Diana S‐L Chow et al. · 2025 · Journal of Medicinal Chemistry
  8. Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance
    Woo Hyun Park · 2026 · The Journal of Pathology
  9. LKB1 inactivation elicits an NNMT-mediated methyl sink and confers dependence on PRMT5 in lung cancer
    Wen Mi, Xinyi Xia, Yun Xue, Liucheng Li, Li Yang, Xincheng Yang, Jie Xu, Xinlei Cai, Yijia Zhou, Lingzhi Zhu et al. · 2026 · Cell Reports
  10. Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in non-small cell lung cancer
    Peiqiang Yan, Weiwei Jiang, Xutong Xue, Tao Hou, Jingchao Wang, Daoyuan Huang, Li Chen, Hiroyuki Inuzuka, Xiaoming Dai, Wenyi Wei · 2026 · Cancer Letters
  11. Biologie moléculaire et prise en charge des patients atteints d’adénocarcinomes du poumon
    Laure Gibault, Aurélie Cazes, Céline Narjoz, Hélène Blons · 2014 · Revue de Pneumologie Clinique
  12. Oxidative Stress in Cell Signaling and Cell Fate Determination Under Glucose Starvation
    Yi Ren, Charlie Cheong, Han‐Ming Shen · 2021 · Springer eBooks
  13. Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
    Silvana Andrea Mouron, María J. Bueno, Manuel Muñoz, Miguel Quintela-Fino · 2021 · Oncoscience
  14. Targeting Fatty Acid Metabolism in Head and Neck Cancer
    Ji Hoon Kim, Minhee Ku, Jaemoon Yang, Hyung Kwon Byeon · 2021 · Korean Journal of Otorhinolaryngology - Head and Neck Surgery
  15. Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    Milica Momcilovic, Sean T. Bailey, Jason T. Lee, Charles Zamilpa, Anthony Jones, G. A. Abdelhady, James Robert Mansfield, Kevin P. Francis, David B. Shackelford · 2018 · Journal of Visualized Experiments
  16. Improving platinum-based treatments for advanced non-small cell lung cancer
    Ada W.Y. Leung · 2016 · cIRcle (University of British Columbia)
  17. A polypeptide D-TTK001 targeting HBx controls cccDNA against HBV
    Xiaodong Zhang, Hongfeng Yuan, Shuai Zhang, Shuqin Zhang, Lina Zhao, Hongwei Gao, Guang Yang, Shuai Zhang, Haolin Yun, Changliang Shan et al. · 2020 · Research Square
  18. Metformin Resistant MDA-MB-468 Cells Exhibit EMT-like Phenotype and Increased Migration Capacity
    Şahika Cıngır Köker, Banu Yalçin, İrem Doğan · 2021 · Research Square
  19. Metformin decreases Cyp26a1 to prevent hepatocarcinogenesis through down- regulating CD8 + T cells
    Weizhi He, Miaomiao Chen, Chong V. Li, Xicheng Wang, Wenjian Chen, Lili Pan, Yangyang Cui, Yu Zhao, Guoxiu Wu, Yang Yang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  20. LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS -mutant lung cancers
    Chendi Li, Mohammed Usman Syed, Anahita Nimbalkar, Yi Shen, Cameron Fraser, Zintis Inde, Xingping Qin, Jian Ouyang, Johannes Kreuzer, Sarah Elizabeth Clark et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
    Phaedra C. Ghazi, Kayla T. O’Toole, Sanjana Srinivas Boggaram, Michael T. Scherzer, Mark R. Silvis, Yun Zhang, Madhumita Jagannathan‐Bogdan, Bryan D. Smith, Guillermina Lozano, Daniel Lee Flynn et al. · 2024 · eLife
  22. Exposome du cancer : reprogrammation métabolique du cancer du poumon par les nitrosamines spécifiques de la fumée de tabac
    Saharnaz Sarlak · 2021 · theses.fr (ABES)
  23. THE METABOLOMIC EFFECTS OF METFORMIN ON COLON CANCER
    Jennifer W. Harris · 2015 · UKnowledge (University of Kentucky)
  24. Targeting Redox Homeostasis in LKB1-deficient NSCLC
    Jamey D. Young, Young Mi Whang · 2014 · Defense Technical Information Center (DTIC)
  25. Novel Posttranslational Modification in LKB1 Activation and Function
    Szu-Wei Lee · 2014 · Digital Commons-TMC (Texas Medical Center)
  26. Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence
    Samantha Dwyer · 2013 · Scholarly Commons (University of Pennsylvania)
  27. Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells* Metformina sinergicamente potencializa os efeitos antiproliferativos de cisplatina e etoposídeo em linhagem de células de câncer humano de pulmão NCI-H460
    Sarah Fernandes Teixeira, Ian Victor Silva, Letícia Batista Azevedo Rangel · 2013
  28. Metformin aktiviert im Duodenum einen AMPK-abhängigen Signalweg
    Marie‐Christine Simon · 2015 · Info Diabetologie
  29. Metformin and Cancer: past, present, future
    Camille Loubière, Béatrice Dirat, Frédéric Bost · 2014
  30. Coactivation d’AMPK et de mTORC1
    Jérôme Tamburini, Laury Poulain, Didier Bouscary, Pierre Sujobert · 2015 · médecine/sciences
  31. Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer
    Rebecca R. Britt · 2014
  32. Biomarkers for Early Detection of Familial Breast Cancer
    Burak Yılmaz, Catherine A. Moroski-Erkul, Ömer Faruk Hatipoğlu, Esra Gündüz, Debmalya Barh, Mehmet Gündüz · 2015 · CRC Press eBooks
  33. Omics of Hereditary Breast Cancer
    Catherine A. Moroski-Erkul, Burak Yılmaz, Esra Gündüz, Mehmet Gündüz · 2014 · Springer eBooks
  34. Metformin as Adjuvant Therapy in Ovarian and Endometrial Cancers
    Leslie Horn Clark, Victoria Lin Bae-Jump · 2017 · Energy balance and cancer
  35. Targeting CAIX with small molecules
    Parvathaneni · 2017
  36. An investigation of metabolic vulnerabilities in chronic myeloid leukaemic stem cells
    Elodie M. Kuntz · 2017 · Enlighten: Theses (The University of Glasgow)
  37. Investigating Cooperation between KEAP1 and LKB1 Inactivation in Lung Adenocarcinoma
    Landon J. Inge · 2017
  38. The role of respiration in supporting cell proliferation
    Dan Y. Gui · 2017 · DSpace@MIT (Massachusetts Institute of Technology)
  39. ENHANCING RADIATION SENSITIVITY IN NON-SMALL CELL LUNG CANCER
    Yifan Wang · 2018 · Digital Commons-TMC (Texas Medical Center)
  40. Mechanisms of activation and inhibition of the metabolic regulator AMP-activated protein kinase (AMPK)
    Toby A. Dite · 2018 · Minerva Access (University of Melbourne)
  41. Unravelling Lung Cancer Heterogeneity and Associated Therapeutic Responses using in vivo and ex vivo Model Systems
    Ashwini Sakrepatna Nagaraj · 2018 · Työväentutkimus Vuosikirja
  42. Liver Kinase B1 (LKB1) Loss Has its p-ERKs: ERK Inactivation as a Vulnerability in NSCLC With LKB1 Mutations
    Irati Macaya, Rodrigo Entrialgo‐Cadierno, Karmele Valencia, Silvestre Vicent · 2020 · Journal of Thoracic Oncology
  43. Crosstalk between PIM and LKB1 kinases regulates AMPK phosphorylation and tumorigenic growth
    Kwan Long Mung, William B. Eccleshall, Niina M. Santio, Adolfo Rivero‐Müller, Päivi J. Koskinen · 2021 · Research Square
  44. BURNOUT IN HIGH PRESSURE WATER. AN APPRECIATION OF RECENT AMERICAN CORRELATIONS
    Robert W. Bowring, Huey A. Roberts, Richard W. Scott · 1958 · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  45. Metformin Resistant MDA-MB-468 Cells Exhibit EMT-like Phenotype and Increased Migration Capacity
    Şahika Cıngır Köker, Banu Yalçin, İrem Doğan · 2021 · Research Square
  46. Faculty Opinions recommendation of The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Kristiina Vuori, Ming Zhao · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  47. Impacto da via de sinalização AMPK na modulação da resposta imune antitumoral por linfócitos T CD4>sup<+>/sup< e CD8>sup<+>/sup<
    Amanda Campelo Melo Feitosa · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  48. CAIX
    Simon Johannes Antonius van Kuijk · 2016
  49. Faculty Opinions recommendation of In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer.
    Navdeep S. Chandel · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  50. Data from Altered Mitochondria Functionality Defines a Metastatic Cell State in Lung Cancer and Creates an Exploitable Vulnerability
    Chen-Hua Chuang, Madeleine Dorsch, Philip Dujardin, Sukrit Silas, Kristina Ueffing, Johanna Maria Hölken, Dian Yang, Monte M. Winslow, Barbara M. Grüner · 2023
  51. Data from Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer
    Rui Li, Ramin Salehi‐Rad, William Crosson, Milica Momcilovic, Raymond J. Lim, Stephanie L. Ong, Zi Ling Huang, Tian-hao Zhang, Jensen W. Abascal, Camelia Dumitras et al. · 2023
  52. Data from Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma
    Chuan Li, Wen-Yang Lin, Hira A. Rizvi, Hongchen Cai, Christopher D. McFarland, Zoe N. Rogers, Maryam Yousefi, Ian P. Winters, Charles M. Rudin, Dmitri A. Petrov et al. · 2023
  53. Data from Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
    Vanessa E. Zannella, Alan Dal Pra, Hala Muaddi, Trevor D. McKee, Shawn Stapleton, Jenna R. Sykes, Rachel Glicksman, Selim Chaib, Paul Zamiara, Michael Milosevic et al. · 2023
  54. Data from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
    Benjamin D. Stein, John R. Ferrarone, Eric E. Gardner, Jae Won Chang, David Wu, Pablo E. Hollstein, Roger J. Liang, Min Yuan, Qiuying Chen, John S. Coukos et al. · 2023
  55. Data from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
    Benjamin D. Stein, John R. Ferrarone, Eric E. Gardner, Jae Won Chang, David Wu, Pablo E. Hollstein, Roger J. Liang, Min Yuan, Qiuying Chen, John S. Coukos et al. · 2023
  56. Data from Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma
    Sanchareeka Dey, Adnin Ashrafi, Chantal Vidal, Nivesh Jain, Sarada Preeta Kalainayakan, Poorva Ghosh, Parinaz Sadat Alemi, Narges Salamat, Purna Chaitanya Konduri, Jung‐whan Kim et al. · 2023
  57. Data from Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma
    Sanchareeka Dey, Adnin Ashrafi, Chantal Vidal, Nivesh Jain, Sarada Preeta Kalainayakan, Poorva Ghosh, Parinaz Sadat Alemi, Narges Salamat, Purna Chaitanya Konduri, Jung‐whan Kim et al. · 2023
  58. Nomogram of myelosuppression and survival prognosis in patients with brain metastases from non-small cell lung adenocarcinoma by intrathecal injection of pemetrexed via the Ommaya Reservoir
    Junhao Luo, Yue Shen, Bin Li, Xiangping Li · 2023 · Research Square
  59. eLife Assessment: Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
    Rachel Evans · 2024 · eLife
  60. Reviewer #2 (Public Review): Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
    2024 · eLife
  61. Author response: Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
    Phaedra C. Ghazi, Kayla T. O’Toole, Sanjana Srinivas Boggaram, Michael T. Scherzer, Mark R. Silvis, Yun Zhang, Madhumita Jagannathan‐Bogdan, Bryan D. Smith, Guillermina Lozano, Daniel Lee Flynn et al. · 2024 · eLife
  62. Additional file 3 of PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1
    Mung, Kwan Long, William B. Eccleshall, Niina M. Santio, Adolfo Rivero‐Müller, Päivi J. Koskinen · 2021 · Figshare
  63. Additional file 2 of PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1
    Mung, Kwan Long, William B. Eccleshall, Niina M. Santio, Adolfo Rivero‐Müller, Päivi J. Koskinen · 2021 · Figshare
  64. Additional file 1 of Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses
    Xu, Ke, Weinan Lu, Airu Yu, Wu, Hongwei, He, Jie · 2024 · Figshare
  65. Effects of Metformin on Leukemia: Biological Mechanisms, Targets, and Treatment Possibilities
    Parisa Dana, Abdolkhalegh Deezagi · 2025 · Journal of Blood and Cancer
  66. Hereditary cancer syndromes linked to oxidative phosphorylation insufficiency
    Bob Kaplan, Tomás Duraj, Derek C. Lee, Thomas N. Seyfried · 2025 · ONCOLOGIE
  67. OLD DRUG, NEW USES: A COMPREHENSIVE REVIEW OF THE EVOLVING ROLE OF METFORMIN IN ONCOLOGY
    Bernard Myszewski, Maria Rajkowska, Aleksandra Włodarczyk, Norbert Grabias, Jędrzej Piotrowski, Paulina Jarząbek, Julia Weronika Mieszkowska, Radosław Gryko, Anna Kinga Tejchma, Łukasz Dominik Woźniak · 2026 · International Journal of Innovative Technologies in Social Science
  68. Caractérisation fonctionnelle du complexe LKB1/STRADß au cil primaire et les conséquences au cours de la tumorigenèse
    Pauline Maurin · 2016 · theses.fr (ABES)
  69. Targeting CAIX with small molecules : design, synthesis and biological efficacy
    Nanda Kumar Parvathaneni · 2017
  70. Biochemical characterization of mTORC1 regulation by glutamine metabolism
    Clément Bodineau · 2020 · theses.fr (ABES)
  71. Chimiothérapie métronomique : stratégie thérapeutique prometteuse de prise en charge de l'hétérogénéité intratumorale par action sur le métabolisme énergétique pour contrôler la résistance aux traitements anti-cancéreux
    Maryna Bondarenko · 2021 · theses.fr (ABES)
  72. Modulation of tumor immunogenicity with AMPK activation in acute myeloid leukemia
    Johanna Mondésir · 2021 · theses.fr (ABES)
  73. EVT-701 : targeting electron transport chain complex I as therapeutic approach in cancer
    Raquel Luna Yolba · 2021 · theses.fr (ABES)
  74. Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
    Zhen Sun, Bernard Linarés, Cassidy Urdiales, Fiyad Al-sarmi, Boyuan Sang, Nagireddy Putluri, Jeanine L. Van Nostrand · 2026 · Science Advances
  75. LKB1 Loss Sensitizes Lung Tumor Spheres to Mitomet‐Induced Ferroptosis, and These Effects are Enhanced by mTOR Inhibition
    Xueqing Liang, Ali Nakhi, Peter I. Dosa, Gunda I. Georg, Fekadu Kassie · 2026 · Molecular Carcinogenesis
  76. Antitumor efficacy of repurposed phenformin in preclinical models of epithelial ovarian cancer
    Jae‐Joong Kim, Ju‐Yeon Choi, J D Seo, Young‐Jae Cho, Ji‐Yoon Ryu, Jae Ryoung Hwang, Jung‐Joo Choi, Jeong‐Won Lee · 2026 · Biomedicine & Pharmacotherapy
  77. SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
    Emily A. Costa, Barbara Vaz de Mello, Corrin A. Wohlhieter, Subhiksha Nandakumar, Samuel Tischfield, Yingqian Ada Zhan, Harsha Sridhar, Dennis Kinyua, Elisa de Stanchina, Wenfei Kang et al. · 2026 · Translational Oncology
  78. The interplay between BECN1-mediated autophagy, metabolism and the cellular response to ionising radiation
    Lingyi Cai, Verena Jendrossek, Johann Matschke, Silvia Vega-Rubín-de-Celis · 2026 · International review of cytology
  79. STK11/LKB1 Loss in Cancer: From Developmental Constraint to Stress-Adapted Malignancy
    Yu Kang, Yanhong Gao, Xiaoyan Zhang, Hai-Ou Liu, Congjian Xu, Yanying Huo · 2026 · Cancers
  80. Disease-Oriented Drug Repurposing in Lung Cancer: Targeting Metabolic Plasticity and Therapy Resistance
    Tahereh Alinejad, Zeinab Alinejad, Reyhaneh Nekounam Ghadirli, Shabnam Modarresi, Subha Bhassu · 2026 · Pharmaceutical science.
  81. Geno-guided targeting of ferroptosis: a multi-layered network to overcome radioresistance in lung cancer
    Shifang Sang, Guangchao Lv, Shiyun Feng, Hui Zhao, Yulong Ren, Dianlong Jin, Kaizhong Wang · 2026 · Frontiers in Cell and Developmental Biology
  82. Genes, fuel, and fate in lung cancer
    Julia S. Scott, Catrin Lutz, Stefan Preković · 2026 · Biochemical Society Transactions
  83. BindingDB Entry 50048921: New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
    BindingDB · 2019 · UC San Diego
  84. BindingDB Entry 50015393: Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179.
    BindingDB · 2023 · UC San Diego
  85. Mechanisms and Molecular Biology of Major Tumor Suppressors
    Brienne E. Engel · 2014 · Digital Commons - University of South Florida (University of South Florida)